Literature DB >> 17400474

Japanese encephalitis virus production in Vero cells with serum-free medium using a novel oscillating bioreactor.

Hiroko Toriniwa1, Tomoyoshi Komiya.   

Abstract

A novel oscillating bioreactor, BelloCell, was successfully applied for the cultivation of Vero cells using serum-free medium, and the production of Japanese encephalitis virus. The BelloCell requires no air sparging, pumping, or agitation, and thus provides a low shear environment. Owing to its simple design, BelloCell is extremely easy to handle and operate. Using this BelloCell (500 ml culture), Vero cells reached a maximum number of 2.8 x 10(9) cells and the Japanese encephalitis virus yield reached 6.91 x 10(11) PFU, versus 9.0 x 10(8) cells and 2.98 x 10(11) PFU using a spinner flask (500 ml) with microcarriers. The cell yield and virus production using BelloCell were markedly higher than with microcarrier culture. The neutralizing capacity of the Japanese encephalitis virus produced using BelloCell was equal to that using a microcarrier system. Therefore, these benefits should enable BelloCell to be adopted as a simple system for high population density cell culture and virus production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400474     DOI: 10.1016/j.biologicals.2007.02.002

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  12 in total

1.  Real-time monitoring of adherent Vero cell density and apoptosis in bioreactor processes.

Authors:  Emma Petiot; Amal El-Wajgali; Geoffrey Esteban; Cécile Gény; Hervé Pinton; Annie Marc
Journal:  Cytotechnology       Date:  2012-02-25       Impact factor: 2.058

2.  Pharmacodynamic analysis of a serine protease inhibitor, MK-4519, against hepatitis C virus using a novel in vitro pharmacodynamic system.

Authors:  Ashley N Brown; James J McSharry; Jonathan R Adams; Robert Kulawy; Richard J O Barnard; W Newhard; A Corbin; Daria J Hazuda; Arnold Louie; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

3.  Rapid process development of serum-free pseudorabies virus production with the Quality by Design approach.

Authors:  Jianqi Nie; Yang Sun; Fei Han; Yankun Yang; Xiuxia Liu; Chunli Liu; Ye Li; Zhonghu Bai
Journal:  Cytotechnology       Date:  2020-02-21       Impact factor: 2.058

4.  Pre-treatment with Scopolamine Naturally Suppresses Japanese Encephalitis Viral Load in Embryonated Chick Through Regulation of Multiple Signaling Pathways.

Authors:  Arghyadeep Bhattacharjee; Rajarshi Chaudhuri; Jiban Jyoti Dash; Manish Saha; Lopamudra Choudhury; Souvik Roy
Journal:  Appl Biochem Biotechnol       Date:  2021-02-23       Impact factor: 2.926

5.  Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium.

Authors:  Alan Yung-Chih Hu; Yu-Fen Tseng; Tsai-Chuan Weng; Chien-Chun Liao; Johnson Wu; Ai-Hsiang Chou; Hsin-Ju Chao; Anna Gu; Janice Chen; Su-Chen Lin; Chia-Hsin Hsiao; Suh-Chin Wu; Pele Chong
Journal:  PLoS One       Date:  2011-01-24       Impact factor: 3.240

6.  Evaluation of novel disposable bioreactors on pandemic influenza virus production.

Authors:  Chia-Chun Lai; Tsai-Chuan Weng; Yu-Fen Tseng; Jen-Ron Chiang; Min-Shi Lee; Alan Yung-Chih Hu
Journal:  PLoS One       Date:  2019-08-12       Impact factor: 3.240

7.  Production of small ruminant morbillivirus, rift valley fever virus and lumpy skin disease virus in CelCradle™ -500A bioreactors.

Authors:  Halima Rhazi; Najete Safini; Karima Mikou; Meryeme Alhyane; Khalid Omari Tadlaoui; Xiangliang Lin; Nandini P Venkatesan; Mehdi Elharrak
Journal:  BMC Vet Res       Date:  2021-02-27       Impact factor: 2.741

8.  High-Titer Hepatitis C Virus Production in a Scalable Single-Use High Cell Density Bioreactor.

Authors:  Anna Offersgaard; Carlos Rene Duarte Hernandez; Anne Finne Pihl; Nandini Prabhakar Venkatesan; Henrik Krarup; Xiangliang Lin; Udo Reichl; Jens Bukh; Yvonne Genzel; Judith Margarete Gottwein
Journal:  Vaccines (Basel)       Date:  2022-02-07

9.  Utility of a Novel Three-Dimensional and Dynamic (3DD) Cell Culture System for PK/PD Studies: Evaluation of a Triple Combination Therapy at Overcoming Anti-HER2 Treatment Resistance in Breast Cancer.

Authors:  Anusha Ande; Tanaya R Vaidya; Bao N Tran; Michael Vicchiarelli; Ashley N Brown; Sihem Ait-Oudhia
Journal:  Front Pharmacol       Date:  2018-05-01       Impact factor: 5.810

10.  SARS-CoV-2 Production in a Scalable High Cell Density Bioreactor.

Authors:  Anna Offersgaard; Carlos Rene Duarte Hernandez; Anne Finne Pihl; Rui Costa; Nandini Prabhakar Venkatesan; Xiangliang Lin; Long Van Pham; Shan Feng; Ulrik Fahnøe; Troels Kasper Høyer Scheel; Santseharay Ramirez; Udo Reichl; Jens Bukh; Yvonne Genzel; Judith Margarete Gottwein
Journal:  Vaccines (Basel)       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.